These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12429967)

  • 61. Immunohistochemical expression of thrombospondin-1 in invasive vulvar squamous cell carcinoma.
    Tringler B; Grimm C; Sliutz G; Leodolter S; Speiser P; Reinthaller A; Hefler LA
    Gynecol Oncol; 2005 Oct; 99(1):80-3. PubMed ID: 16009408
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer.
    Hibi T; Mori T; Fukuma M; Yamazaki K; Hashiguchi A; Yamada T; Tanabe M; Aiura K; Kawakami T; Ogiwara A; Kosuge T; Kitajima M; Kitagawa Y; Sakamoto M
    Clin Cancer Res; 2009 Apr; 15(8):2864-71. PubMed ID: 19351749
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Aromatase expression in stromal cells of endometrioid endometrial cancer correlates with poor survival.
    Segawa T; Shozu M; Murakami K; Kasai T; Shinohara K; Nomura K; Ohno S; Inoue M
    Clin Cancer Res; 2005 Mar; 11(6):2188-94. PubMed ID: 15788666
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
    Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H
    Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer.
    Ma J; Jiang Y; Jiang Y; Sun Y; Zhao X
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1852-9. PubMed ID: 19120874
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Epithelial and stromal expression of syndecan-2 in pancreatic carcinoma.
    Hrabar D; Aralica G; Gomercic M; Ljubicic N; Kruslin B; Tomas D
    Anticancer Res; 2010 Jul; 30(7):2749-53. PubMed ID: 20683009
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer.
    Masugi Y; Yamazaki K; Hibi T; Aiura K; Kitagawa Y; Sakamoto M
    Hum Pathol; 2010 Aug; 41(8):1061-8. PubMed ID: 20413143
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.
    Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z
    World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stromal thrombospondin-1 expression is correlated with progression of esophageal squamous cell carcinomas.
    Oshiba G; Kijima H; Himeno S; Kenmochi T; Kise Y; Tanaka H; Nishi T; Chino O; Shimada H; Machimura T; Tsuchida T; Nakamura M; Ueyama Y; Tanaka M; Tajima T; Makuuchi H
    Anticancer Res; 1999; 19(5C):4375-8. PubMed ID: 10650779
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Clinical implication of BRSK2 expression in pancreatic ductal adenocarcinoma].
    Niu GM; Ji Y; Jin DY; Hou J; Lou WH
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(16):1084-8. PubMed ID: 20646422
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.
    Ioachim E; Michael MC; Salmas M; Damala K; Tsanou E; Michael MM; Malamou-Mitsi V; Stavropoulos NE
    BMC Cancer; 2006 May; 6():140. PubMed ID: 16732887
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
    Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
    Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Periostin, a matrix specific protein, is associated with proliferation and invasion of pancreatic cancer.
    Ben QW; Jin XL; Liu J; Cai X; Yuan F; Yuan YZ
    Oncol Rep; 2011 Mar; 25(3):709-16. PubMed ID: 21225237
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Artemin and GFRalpha3 expressions and their relevance to perineural invasiveness and metastasis of pancreatic carcinoma].
    Zhu DL; Luo DL; Luo G; Wang B; Gao JM
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):428-32. PubMed ID: 19304517
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
    Nakamura H; Horita S; Senmaru N; Miyasaka Y; Gohda T; Inoue Y; Fujita M; Meguro T; Morita T; Nagashima K
    Oncol Rep; 2002; 9(4):751-5. PubMed ID: 12066203
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinicopathological significance of the expression of carbonic anhydrase II in human pancreatic invasive ductal cancer].
    Sheng WW; Zhou JP; Kong FM; Li YJ; Dong M
    Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):728-31. PubMed ID: 23157907
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of Ezrin and phosphorylated Ezrin (pEzrin) in pancreatic ductal adenocarcinoma.
    Cui Y; Li T; Zhang D; Han J
    Cancer Invest; 2010 Mar; 28(3):242-7. PubMed ID: 20158339
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma.
    Einama T; Kamachi H; Nishihara H; Homma S; Kanno H; Takahashi K; Sasaki A; Tahara M; Okada K; Muraoka S; Kamiyama T; Matsuno Y; Ozaki M; Todo S
    Pancreas; 2011 Nov; 40(8):1276-82. PubMed ID: 21775916
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Wen Z; Liao Q; Zhao J; Hu Y; You L; Lu Z; Jia C; Wei Y; Zhao Y
    Ann Surg Oncol; 2014 Jan; 21(1):125-32. PubMed ID: 24132627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.